TrialBlood cancer journal2014

Ofatumumab and high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.

J E Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.